Ronald Zolty is a Cardiology physician affiliated with University of Nebraska Medical Center. OpenAlex indexes 226 publications with 2,160 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Emile @ 42nd St
Omaha, NE 681982301
Telephone
402-559-8888Registry record last updated 29 Mar 2018.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202544 payments$46,005openpaymentsdata.cms.gov ↗
- Alnylam Pharmaceuticals Inc.Program year202534 payments$36,738openpaymentsdata.cms.gov ↗
- Actelion Pharmaceuticals US, Inc.Program year202560 payments$36,625openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.5%Soluble Guanylate Cyclase Stimulator9.1%Adempas100%Part D≥45 patientsAldosterone antagonist (MRA)7.6%Spironolactone96%Eplerenone4%Part D<11 patients+ 15 more classes in this area
Metabolism & gastrointestinal
22.8%SGLT2 inhibitor12.1%Farxiga80%Jardiance18%Dapagliflozin3%Part D<11 patientsGLP-1 receptor agonist3.6%Ozempic100%Part D≥29 patients+ 5 more classes in this area
Blood & clotting
12.5%Prostacyclin Receptor Agonist4.9%Uptravi100%Part D≥29 patientsFactor Xa inhibitor3.1%Eliquis76%Xarelto24%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Preoperative Amiodarone and Primary Graft Dysfunction in Heart Transplantation
Annals of Pharmacotherapy
2024 - Impact of digoxin utilization on clinical outcomes following left ventricular assist device implantation
The International Journal of Artificial Organs
2022
Similar KOLs
Other experts from the same institution or the same specialty.
James Armitage, MD
University of Nebraska Medical Center
Julie Vose, MD
University of Nebraska Medical Center
Kathleen Moore, MD
University of Nebraska Medical Center
Ted Mikuls, MD
University of Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”